The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reno, Theresa A.
Fidler, John M.
Kim, Jae Y.
Raz, Dan J.
Funding for this research was provided by:
National Institutes of Health (5K12CA001727-20)
unspecified valid from 2016-07-11